* : Drug discontinued (product withdrawn), **: Limited availability due to global supply pressures, ***: Becoming increasingly popular for weight loss, d: Days, GIP: Glucose-dependent insulinotropic polypeptide, GLP: Glucagon-like peptide, h: Hours, RA: Receptor agonists The safety and efficacy profile of tirzepatide and semaglutide Long-term cardiovascular outcome trials with GLP-1RA have confirmed that GLP-1RA are safe and do not increase the long-term risk of major adverse cardiovascular events (MACE)
Targeting ACSL4, a key lipid metabolism enzyme, reduces neuronal MDA levels by 54% (Liao et al., 2024)
doi:10.1111/jth.13970 Martinez JA, Qeadan F, Burge MR
The TRIUMPH Clinical Trial Program for Retatrutide Data, Milestones, and Outcomes The clinical development of Retatrutide is organized under a massive, multinational umbrella known as the TRIUMPH program
Local vs
CoolSculpting is based on the science of cryolipolysis and is an effective treatment for freezing fat cells